Skip to content

13G/A filed by Bain Capital Life Sciences Opportunities III, LP

Bain Capital Life Sciences Opportunities III, LP reported 21,209,188 CABA shares, 9.57% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 12:00:02 UTC.

Accession
0001193125-26-461980
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Stake

Shares
21,209,188
Percent of class
9.57%
Event date
2026-09-30

How the shares relate across the reporting persons: one reporting person counts. The page shows the largest row.

Read for the filer group Bain Capital Life Sciences Investors, LLC.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
Bain Capital Life Sciences Opportunities III, LPPN021,209,188021,209,18821,209,1889.57%